Irina Lezama-Cardoso

C.p. 04510
La Ciudad, DUR 04510, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model.

The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model.

Journal: Biochemical pharmacology

Published: August 06, 2025

Chronological activation of the NLRP3 inflammasome/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma.

Chronological activation of the NLRP3 inflammasome/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma.

Journal: Toxicology mechanisms and methods

Published: July 01, 2025

Naringenin attenuates early hepatocarcinogenesis induced by a MASH model.

Naringenin attenuates early hepatocarcinogenesis induced by a MASH model.

Journal: Annals of hepatology

Published: November 15, 2024

Serum α-SMA is a potential noninvasive biomarker of liver fibrosis.

Serum α-SMA is a potential noninvasive biomarker of liver fibrosis.

Journal: Toxicology mechanisms and methods

Published: August 02, 2023

Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway.

Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway.

Journal: Biochemical pharmacology

Published: May 22, 2023

Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals.

Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals.

Journal: European journal of gastroenterology & hepatology

Published: March 26, 2023

The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male rats.

The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male rats.

Journal: Canadian journal of physiology and pharmacology

Published: February 06, 2023

Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH.

Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH.

Journal: Annals of hepatology

Published: September 14, 2022

Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.

Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model.

Journal: International journal of molecular sciences

Published: August 15, 2022

Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways.

Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways.

Journal: Annals of hepatology

Published: January 10, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026